Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)
Germany
· Delayed Price · Currency is EUR 0.740
-0.010 (-1.33%)
At close: Dec 5, 2025
FRA:XIN Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,164 | 1,154 | 1,378 | 2,129 | 772 | 574 | Upgrade
|
| Market Cap Growth | -3.20% | -16.23% | -35.28% | 175.78% | 34.40% | 15.79% | Upgrade
|
| Enterprise Value | 1,228 | 1,254 | 1,471 | 2,125 | 922 | 681 | Upgrade
|
| Last Close Price | 0.74 | 0.66 | 0.58 | 0.81 | 0.45 | 0.28 | Upgrade
|
| PE Ratio | 25.44 | 18.56 | 21.75 | 38.17 | 16.00 | 14.12 | Upgrade
|
| PS Ratio | 1.14 | 1.03 | 1.33 | 2.09 | 0.85 | 0.76 | Upgrade
|
| PB Ratio | 1.80 | 1.67 | 2.26 | 3.61 | 1.53 | 1.35 | Upgrade
|
| P/TBV Ratio | 2.12 | 1.97 | 2.66 | 4.30 | 1.86 | 1.65 | Upgrade
|
| P/FCF Ratio | 36.15 | 56.20 | - | 30.56 | 563.90 | 32.76 | Upgrade
|
| P/OCF Ratio | 22.33 | 23.73 | 40.71 | 20.70 | 21.52 | 10.92 | Upgrade
|
| EV/Sales Ratio | 1.20 | 1.12 | 1.42 | 2.09 | 1.01 | 0.91 | Upgrade
|
| EV/EBITDA Ratio | 10.19 | 9.03 | 11.24 | 16.45 | 7.93 | 6.45 | Upgrade
|
| EV/EBIT Ratio | 23.20 | 18.56 | 22.52 | 33.62 | 16.50 | 11.86 | Upgrade
|
| EV/FCF Ratio | 38.13 | 61.05 | - | 30.51 | 673.39 | 38.85 | Upgrade
|
| Debt / Equity Ratio | 0.28 | 0.32 | 0.28 | 0.32 | 0.45 | 0.49 | Upgrade
|
| Debt / EBITDA Ratio | 1.52 | 1.58 | 1.32 | 1.45 | 1.95 | 1.95 | Upgrade
|
| Debt / FCF Ratio | 5.66 | 10.74 | - | 2.70 | 166.46 | 11.75 | Upgrade
|
| Asset Turnover | 0.95 | 0.98 | 0.98 | 0.96 | 0.91 | 0.89 | Upgrade
|
| Inventory Turnover | 5.40 | 5.01 | 4.58 | 4.93 | 4.48 | 3.77 | Upgrade
|
| Quick Ratio | 0.85 | 0.85 | 0.76 | 0.68 | 0.65 | 0.59 | Upgrade
|
| Current Ratio | 1.31 | 1.33 | 1.33 | 1.09 | 1.10 | 1.13 | Upgrade
|
| Return on Equity (ROE) | 7.59% | 9.74% | 11.09% | 10.65% | 10.28% | 10.68% | Upgrade
|
| Return on Assets (ROA) | 3.06% | 3.69% | 3.87% | 3.73% | 3.50% | 4.24% | Upgrade
|
| Return on Capital (ROIC) | 4.01% | 4.90% | 5.39% | 5.28% | 4.88% | 5.93% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 8.20% | 8.80% | 9.10% | 8.40% | 9.70% | Upgrade
|
| Earnings Yield | 3.93% | 5.39% | 4.60% | 2.62% | 6.25% | 7.08% | Upgrade
|
| FCF Yield | 2.77% | 1.78% | -0.55% | 3.27% | 0.18% | 3.05% | Upgrade
|
| Dividend Yield | 3.91% | 5.48% | 5.46% | 3.34% | 4.57% | 6.81% | Upgrade
|
| Payout Ratio | 55.78% | 48.05% | 35.43% | 39.66% | 42.59% | 39.05% | Upgrade
|
| Buyback Yield / Dilution | 0.13% | 0.54% | -3.20% | -6.93% | 0.02% | -0.86% | Upgrade
|
| Total Shareholder Return | 4.04% | 6.02% | 2.26% | -3.58% | 4.59% | 5.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.